Table 3 Survival End Points of Included Studies
Endpoint | Overall (N = 41) |
|---|---|
Endpoint | |
 All-Cause Mortality | 12 (29.3%) |
 Cardiovascular Mortality | 4 (9.8%) |
 Components of composite endpoint | 2 (4.9%) |
 Components of the composite endpoint, MI, PCI, CABG, CVA and all-cause mortality | 2 (4.9%) |
 Composite | 17 (41.5%) |
 Default from Treatment | 1 (2.4%) |
 Development of Anaemia | 1 (2.4%) |